ITP
Iron Triangle Partners Portfolio holdings
AUM
$632M
This Quarter Return
+4.75%
1 Year Return
+26.53%
3 Year Return
+134.07%
5 Year Return
+312.1%
10 Year Return
–
AUM
$634M
AUM Growth
+$634M
(-26%)
Cap. Flow
-$199M
Cap. Flow
% of AUM
-31.34%
Top 10 Holdings %
Top 10 Hldgs %
53.61%
Holding
34
New
12
Increased
4
Reduced
11
Closed
7
Top Buys
| 1 |
Tenet Healthcare
THC
|
$28.2M |
| 2 |
AstraZeneca
AZN
|
$27.7M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$26.6M |
| 4 |
Guardant Health
GH
|
$25.6M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$17.7M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$61.1M |
| 2 |
Agilent Technologies
A
|
$45.4M |
| 3 |
AbbVie
ABBV
|
$38M |
| 4 |
Exact Sciences
EXAS
|
$33.7M |
| 5 |
HealthEquity
HQY
|
$32.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
DaVita
DVA
$9.85B
| $48.9M | 7.71% | 319,566 +59,142 | +23% | +$9.05M |
|
2
Cardinal Health
CAH
$35.5B
| $41.3M | 6.52% | 300,000 +113,998 | +61% | +$15.7M |
|
|
3
AbbVie
ABBV
$372B
| $40.4M | 6.37% | 192,819 -181,193 | -48% | -$38M |
|
4
Teva Pharmaceuticals
TEVA
$21.1B
| $34.1M | 5.37% | 2,217,730 +17,694 | +0.8% | +$272K |
|
5
Boston Scientific
BSX
$156B
| $33.5M | 5.28% | 332,167 -162,842 | -33% | -$16.4M |
|
6
Globus Medical
GMED
$8.27B
| $31.6M | 4.98% | 431,221 -412,792 | -49% | -$30.2M |
|
|
7
Tenet Healthcare
THC
$16.3B
| $28.2M | 4.44% | +209,454 | New | +$28.2M |
|
8
Insulet
PODD
$23.9B
| $27.8M | 4.39% | 106,029 -47,985 | -31% | -$12.6M |
|
|
9
AstraZeneca
AZN
$248B
| $27.7M | 4.36% | +376,330 | New | +$27.7M |
|
|
ONC
10
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $26.6M | 4.2% | +97,840 | New | +$26.6M |
|
|
11
Guardant Health
GH
$8.41B
| $25.6M | 4.03% | +600,867 | New | +$25.6M |
|
|
12
Agilent Technologies
A
$35.7B
| $24.4M | 3.84% | 208,438 -387,888 | -65% | -$45.4M |
|
13
Merit Medical Systems
MMSI
$5.36B
| $24.3M | 3.83% | 229,738 -177,284 | -44% | -$18.7M |
|
14
Envista
NVST
$3.52B
| $21.3M | 3.35% | 1,232,798 -967,202 | -44% | -$16.7M |
|
15
Doximity
DOCS
$12.7B
| $20.9M | 3.29% | 360,000 +47,425 | +15% | +$2.75M |
|
|
16
Alnylam Pharmaceuticals
ALNY
$58.5B
| $17.7M | 2.78% | +65,409 | New | +$17.7M |
|
17
AdaptHealth
AHCO
$1.28B
| $17.5M | 2.76% | +1,614,045 | New | +$17.5M |
|
18
Twist Bioscience
TWST
$1.63B
| $16.6M | 2.62% | 423,913 -68,558 | -14% | -$2.69M |
|
19
argenx
ARGX
$43.6B
| $16.5M | 2.6% | 27,874 -7,126 | -20% | -$4.22M |
|
20
Neurocrine Biosciences
NBIX
$13.8B
| $16.2M | 2.56% | 146,836 -171,359 | -54% | -$19M |
|
21
Jazz Pharmaceuticals
JAZZ
$7.75B
| $16.1M | 2.54% | +130,000 | New | +$16.1M |
|
22
Adaptive Biotechnologies
ADPT
$2.01B
| $15.9M | 2.5% | +2,134,061 | New | +$15.9M |
|
23
Intuitive Surgical
ISRG
$170B
| $14.9M | 2.34% | 30,000 -45,000 | -60% | -$22.3M |
|
24
Bio-Techne
TECH
$8.5B
| $14.7M | 2.31% | +250,000 | New | +$14.7M |
|
25
BrightSpring Health Services
BTSG
$4.2B
| $13.1M | 2.06% | +722,341 | New | +$13.1M |
|